News | Magnetic Resonance Imaging (MRI) | November 27, 2023

SyntheticMR announced that its next-generation imaging solution with isotropic resolution, SyMRI 3D, is FDA-pending for clinical use in the United States

SyntheticMR announced that its next-generation imaging solution with isotropic resolution, SyMRI 3D, is FDA-pending for clinical use in the United States

November 27, 2023 — SyntheticMR announced that its next-generation imaging solution with isotropic resolution, SyMRI 3D, is FDA-pending for clinical use in the United States. 

"We are thrilled to receive 510(k) pending status for SyMRI 3D,” says Ulrik Harrysson, CEO at SyntheticMR AB. “SyMRI 3D represents a pivotal leap forward in medical imaging, offering new possibilities for diagnosis and treatment.”

SyMRI 3D is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within SyMRI's post-processing solution. SyMRI 3D enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. 

Furthermore, the exceptional resolution provided by SyMRI 3D facilitates comprehensive lesion analysis, ensuring a more accurate and in-depth assessment of medical conditions.

"This advanced SyMRI sequence introduces 3D resolution to quantitative values and tissue segmentations, ensuring the same level of precision in quantification as achieved with SyMRI's 2D imaging," says Kyle Frye, CCO & President of SyntheticMR Inc. “Receiving 510(k) clearance for SyMRI 3D will allow us to enable physicians to make better, more informed decisions using quantitative imaging.”

For more information: www.syntheticmr.com

Find more RSNA23 conference coverage here


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Time February 20, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
Sponsored Content | Videos | Enterprise Imaging

Clinicians and referring physicians need fast, secure access to both patient data and their diagnostic or viewing tool ...

Time February 15, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...

Time February 13, 2024
arrow
News | Artificial Intelligence

February 13, 2024 — Nanox, an innovative medical imaging technology company, today announced that its deep-learning ...

Time February 13, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | FDA

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
Subscribe Now